Starget Pharma
Starget Pharma is a clinical company developing a new class of Smart Targeted Radioligands (STRs) for precision oncology of hard-to-heal cancers.
Our AI-driven peptide-based discovery engine enables the rapid identification of radioligands that deliver high-energy radiation precisely to tumoral and metastatic cancer cells, while sparing healthy tissues.
We are transforming peptides into next-generation radiopharmaceuticals through our proprietary in silico platform—built upon peptide Backbone Dynamics. This platform simulates and optimizes 3D molecular conformations to identify drug-like radioligand candidates with exceptional affinity, selectivity, and pharmacokinetic properties.
Starget is committed to advancing the science of radiopharmaceuticals and providing new hope to cancer patients worldwide.
